RecruitingNot ApplicableNCT07102147
Telehealth Collaborative Care Model (CoCM) in Lung Cancer
Increasing Adoption of a Telehealth-Delivered Collaborative Care Program for Patients With Lung Cancer: A Pilot Study
Sponsor
Abramson Cancer Center at Penn Medicine
Enrollment
30 participants
Start Date
Aug 18, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this trial is to compare the impact of two outreach strategies (high touch vs. standard outreach) on a collaborative care program delivered via telehealth to patients with lung cancer.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Are aged 18 years or older.
- Are currently being seen by Penn Medicine Thoracic Oncology for lung cancer treatment or survivorship care.
- Are referred to collaborative care by a Penn Medicine Thoracic Oncology clinician for treatment of depression, anxiety, or other psycho-therapy services.
Exclusion Criteria2
- Are already receiving psycho-therapy treatment services outside of Penn Medicine's collaborative care program, Penn Integrated Care (PIC).
- Have a significant and/or untreated medical and/or psychiatric co-morbidity (e.g., other cancers, schizophrenia, acute suicidal and/or homicidal ideation) that make them ineligible for the Penn CoCM program.
Interventions
BEHAVIORALHigh Touch Outreach
Gain-framed message, informational flyer, and direct request
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07102147
Related Trials
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
NCT071689933 locations
Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis
NCT0746584812 locations
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
NCT074399911 location
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
NCT074106761 location
Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?
NCT074184501 location